Related Experiment Video
Updated: Oct 13, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
The cell membrane repair protein MG53 modulates transcription factor NF-κB signaling to control kidney fibrosis
Haichang Li1, Pu Duann2, Zhongguang Li1
1Department of Surgery, Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio, USA.
Abstract:
Kidney fibrosis is associated with the progression of acute kidney injury to chronic kidney disease. MG53, a cell membrane repair protein, has been shown to protect against injury to kidney epithelial cells and acute kidney injury. Here, we evaluated the role of MG53 in modulation of kidney fibrosis in aging mice and in mice with unilateral ureteral obstruction (UUO) a known model of progressive kidney fibrosis. Mice with ablation of MG53 developed more interstitial fibrosis with age than MG53-intact mice of the same age. Similarly, in the absence of MG53, kidney fibrosis was exaggerated compared to mice with intact MG53 in the obstructed kidney compared to the contralateral unobstructed kidney or the kidneys of sham operated mice. The ureteral obstructed kidneys from MG53 deficient mice also showed significantly more inflammation than ureteral obstructed kidneys from MG53 intact mice. In vitro experiments demonstrated that MG53 could enter the nuclei of proximal tubular epithelial cells and directly interact with the p65 component of transcription factor NF-κB, providing a possible explanation of enhanced inflammation in the absence of MG53. To test this, enhanced MG53 expression through engineered cells or direct recombinant protein delivery was given to mice subject to UUO. This reduced NF-κB activation and inflammation and attenuated kidney fibrosis. Thus, MG53 may have a therapeutic role in treating chronic kidney inflammation and thereby provide protection against fibrosis that leads to the chronic kidney disease phenotype.
Insights
The cell membrane repair protein MG53 protects against kidney fibrosis and inflammation. MG53 deficiency exacerbates kidney fibrosis, while enhancing MG53 levels offers therapeutic potential for chronic kidney disease.
Area of Science:
- Nephrology
- Cell Biology
- Biochemistry
Background:
- Kidney fibrosis is a key factor in the progression of acute kidney injury to chronic kidney disease.
- MG53, a cell membrane repair protein, has demonstrated protective effects against kidney epithelial cell injury and acute kidney injury.
- The role of MG53 in kidney fibrosis, particularly in aging and disease models, requires further investigation.
Purpose of the Study:
- To investigate the role of MG53 in modulating kidney fibrosis in aging mice.
- To evaluate the impact of MG53 deficiency on kidney fibrosis and inflammation in a mouse model of unilateral ureteral obstruction (UUO).
- To explore the therapeutic potential of MG53 in mitigating kidney fibrosis and inflammation.
Main Methods:
- Assessed kidney fibrosis and interstitial fibrosis in aging mice with and without MG53 using histological analysis.
- Utilized the unilateral ureteral obstruction (UUO) model in MG53-deficient and MG53-intact mice to evaluate fibrosis and inflammation.
- Conducted in vitro experiments to determine MG53's interaction with NF-κB signaling in proximal tubular epithelial cells.
- Administered enhanced MG53 expression or recombinant protein to UUO mice to assess therapeutic effects.
Main Results:
- Mice lacking MG53 exhibited increased interstitial fibrosis with age compared to controls.
- MG53 deficiency exacerbated kidney fibrosis and inflammation in the UUO model.
- In vitro studies showed MG53 enters proximal tubular cell nuclei and interacts with p65 subunit of NF-κB.
- Enhanced MG53 levels reduced NF-κB activation, inflammation, and attenuated kidney fibrosis in UUO mice.
Conclusions:
- MG53 plays a protective role against kidney fibrosis and inflammation.
- MG53 deficiency leads to heightened inflammation and fibrosis, potentially through interaction with NF-κB signaling.
- Augmenting MG53 levels presents a potential therapeutic strategy for chronic kidney inflammation and fibrosis, offering protection against chronic kidney disease progression.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Master Transcription Regulators
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Abnormal Proliferation
Negative Regulator Molecules

